| Sep 06 | Sep 05 | Sep 04 | Sep 03 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ||||
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -4.49M | $ -6.20M | $ -3.93M | $ -81.38K |
| EBITDA | $ -4.49M | $ -6.20M | $ -3.92M | $ -66.17K |
| Net Income | $ -5.08M | $ -6.96M | $ -3.99M | $ -82.50K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 20.08M | $ 19.91M | $ 19.45M | $ 35.92K |
| Total Debt | $ 3.12M | $ 3.74M | $ 2.47M | $ 0.00 |
| Net Debt | $ 3.00M | $ 3.38M | $ 2.47M | $ -3.40K |
| Total Liabilities | $ 4.47M | $ 4.15M | $ 3.33M | $ 8.64K |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | ||||
| Free Cash Flow | $ -1.31M | $ -1.23M | $ -562.90K | $ -74.66K |
| Operating Cash Flow | $ -1.30M | $ -1.22M | $ -62.90K | $ -74.66K |
| Investing Cash Flow | ||||
| Financing Cash Flow |
Dermisonics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.